In the order of significance, high gene expression of UBA1, UBA6, and UBA3/NAE2 were associated with significantly shorter survival times in the French glioma dataset (chi = 26.79, p = 2.3 × 10−7, chi = 21.04, p = 4.5 × 10−6, chi = 8.79, p = 3.0 × 10−3, respectively). The gene discussed is UBA6; the disease is central nervous system cancer.